The present invention relates to a new cyclic peptide compound or a salt thereof, which has anti-hepatitis C virus activities based on inhibitory act ivity against the RNA replication of hepatitis C virus replicon, a process f or preparation thereof, a pharmaceutical composition comprising the same, an d a method for prophylactic and/or therapeutic treatment of hepatitis C in a human being or an animal.
